Skip to content

Is internet-delivered therapy more effective than internet-delivered brief support in reducing depressive symptoms in adolescents?

ERiCA I-PDT for depressed adolescents – a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN16206254
Enrollment
72
Registered
2019-01-25
Start date
2019-01-03
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate depression in adolescents Mental and Behavioural Disorders

Interventions

Directly after inclusion, participants will be randomized to one of two arms with 1:1 ratio: intervention or control condition. An independent researcher, not involved in the study, will conduct the r

Sponsors

Department of Psychology, Stockholm University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adolescents 15-18 years of age 2. Suffering from mild to moderate symptoms of depression according to a diagnostic interview (MINI 7.0). 3. Have access to a computer/smartphone/tablet with internet connection 4. Able to read, write and speak Swedish without the aid of an interpreter.

Exclusion criteria

Exclusion criteria: 1. Risk of suicidality and/or earlier suicide attempts, 2. Partaking in other psychological treatment, 3. Psychotropic medication not stable since at least three months, 4. Other primary diagnoses in need of other treatment 5. Current fulfillment of any of the following diagnoses: any psychotic disorder, bipolar I/II disorder, antisocial personality disorder, and autism-spectrum disorder. 6. Comorbid drug or alcohol abuse.

Design outcomes

Primary

MeasureTime frame
1. Depressive symptoms will be measured using the Quick Inventory of Depressive Symptomatology in Adolescents (Bernstein et al., 2010) via internet delivered self-rating forms pre-treatment, weekly during treatment and post-treatment. 1.1. In order to fully explore trajectories of change and possible moderating and mediating factors over time, a parallel process latent growth curve strategy will be employed. 2. Differences in efficacy between conditions will be investigated by modelling interaction effects of group and time.

Secondary

MeasureTime frame
1. Anxiety symptoms will be measured weekly using the Generalised Anxiety Disorder 7- item scale (GAD-7; Kroenke et al., 2010). 2. The severity of depression symptoms will be measured pre- and post-treatment using the Montgomery Åsberg Depression Rating Scale (Svanborg & Åsberg, 1994).

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026